Company news
Voyageur Pharmaceuticals Ltd news in 2025
Voyageur Pharmaceuticals Ltd's news releases, calls and decks from 2025, newest first.
Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors With Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion
November 7, 2025
Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion
November 7, 2025
Voyageur Pharmaceuticals Signs Non-Exclusive Distribution & Wholesale Agreement With PHALANX
October 29, 2025
Voyageur Pharmaceuticals Signs Non-Exclusive Distribution & Wholesale Agreement with PHALANX
October 29, 2025
Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Wall Street Expertise to Facilitate U.S. Market Expansion
October 23, 2025
Voyageur Pharmaceuticals Launches U.S. Iodine Feasibility Study to Establish First Fully Integrated North American Contrast Drug Manufacturing Platform
August 25, 2025
Voyageur Pharmaceuticals Initiates First Commercial Shipments of Barium Contrast Products to Canadian Clinics
August 21, 2025
Voyageur Pharmaceuticals Announces Exercise of Warrants for Gross Proceeds of $1.69 Million
August 19, 2025
Voyageur Advances Frances Creek Barite Project With VAST Engagement for Bulk Sample Permit
August 18, 2025
Voyageur Advances Frances Creek Barite Project with VAST Engagement for Bulk Sample Permit
August 18, 2025
Voyageur Pharmaceuticals Grants Deferred Share Units and Options and Accelerates Expiry Date of Warrants
July 14, 2025
Voyageur Pharmaceuticals Signs LOI for Latin America Distribution Partnership Supporting Global Market Expansion
June 24, 2025
Voyageur and Altillion Forge Landmark Alliance to Establish North America's First Vertically Integrated Iodine Drug Supply Chain
June 23, 2025
Voyageur Enters Revenue Stage With First Commercial Sale of Barium Contrast Agents
June 4, 2025
Voyageur Enters Revenue Stage with First Commercial Sale of Barium Contrast Agents
June 4, 2025
Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President
May 12, 2025
Voyageur Pharmaceuticals Announces Changes to Board of Directors and DSU Grant
May 1, 2025
Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results
April 23, 2025
Voyageur Pharmaceuticals Grants Deferred Share Units
April 7, 2025
Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch
April 1, 2025
Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line
March 4, 2025
Voyageur Clarifies Terms of Previously Announced Agreement
March 3, 2025
Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes
February 18, 2025
Voyageur Receives $600K Grant from Alberta Innovates for Product Development
February 5, 2025
Voyageur Secures $687k of Additional Capital from Warrant Exercises
January 23, 2025
Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite
January 15, 2025
Voyageur Commences Testing of Innovative Barium Contrast Product Line in Human Radiology Scans, Paving the Way for Near-Term Market Launch
January 13, 2025